Insider · CIK 0001887046
Edward Stelmakh
Files at OPRX (OptimizeRx Corp). First filing Dec 22, 2025, latest Dec 22, 2025.
In brief
Edward Stelmakh files SEC Form 4 as CFO and COO at OPRX (OptimizeRx Corp). Since Dec 22, 2025, Edward Stelmakh has reported 0 open-market buys worth $0 and 1 open-market sell worth $19k, the latest filed on Dec 22, 2025.
A track record needs three past buys with six months of prices behind them; Edward Stelmakh has 0, so none is measured yet.
The newest scored trade: sold $19k of OPRX on Dec 19, 2025, filed Dec 22, 2025, scored 7 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $19k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
OPRX: OptimizeRx Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 7Weak | OPRXsell OptimizeRx Corp | $19k 1,388 shares | -1% | +226% from low-38% from high |
Transactions
Every row this insider has filed, 22 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -1,381 | $7.71 | $11k | 121,791 | Aug 24, 2026 |
| Dec 23, 2025 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -3,658 | $12.74 | $47k | 123,172 | Dec 23, 2025 |
| Dec 19, 2025 | OPRX OptimizeRx Corp | MOption exercise Common Stock | +5,237 | $0.00 | $0 | 128,218 | Dec 23, 2025 |
| Dec 19, 2025 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -1,388 | $13.51 | $19k | 126,830 | Dec 23, 2025 |
| Dec 19, 2025 | OPRX OptimizeRx Corp | MOption exercise Restricted Stock Unitsderivative | -5,237 | $0.00 | $0 | 5,237 | Dec 23, 2025 |
| Dec 19, 2025 | OPRX OptimizeRx Corp | MOption exercise Common Stock | +5,237 | $0.00 | $0 | 128,218 | Dec 22, 2025 |
| Dec 19, 2025 | OPRX OptimizeRx Corp | SOpen-market sale Common Stock | -1,388 | $13.51 | $19k | 126,830 | Dec 22, 2025 |
| Dec 19, 2025 | OPRX OptimizeRx Corp | MOption exercise Restricted Stock Unitsderivative | -5,237 | $0.00 | $0 | 5,237 | Dec 22, 2025 |
| Oct 3, 2025 | OPRX OptimizeRx Corp | MOption exercise Common Stock | +16,623 | $0.00 | $0 | 127,387 | Oct 7, 2025 |
| Oct 3, 2025 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -4,406 | $18.75 | $83k | 122,981 | Oct 7, 2025 |
| Oct 3, 2025 | OPRX OptimizeRx Corp | MOption exercise Restricted Stock Unitsderivative | -16,623 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Aug 21, 2025 | OPRX OptimizeRx Corp | AGrant or award Common Stock | +15,625 | $0.00 | $0 | 110,764 | Aug 25, 2025 |
| Aug 21, 2025 | OPRX OptimizeRx Corp | AGrant or award Stock Optionderivative | +35,156 | $0.00 | $0 | 35,156 | Aug 25, 2025 |
| Dec 23, 2024 | OPRX OptimizeRx Corp | AGrant or award Common Stock | +41,408 | $0.00 | $0 | 97,295 | Dec 27, 2024 |
| Feb 15, 2024 | OPRX OptimizeRx Corp | AGrant or award Common Stock | +0 | $0.00 | $0 | 33,365 | Dec 27, 2024 |
| Dec 23, 2024 | OPRX OptimizeRx Corp | AGrant or award Stock Optionderivative | +77,742 | $0.00 | $0 | 77,742 | Dec 27, 2024 |
| Dec 19, 2024 | OPRX OptimizeRx Corp | MOption exercise Common Stock | +5,237 | $0.00 | $0 | 38,603 | Dec 20, 2024 |
| Dec 19, 2024 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -1,316 | $4.75 | $6,251 | 37,287 | Dec 20, 2024 |
| Dec 19, 2024 | OPRX OptimizeRx Corp | MOption exercise Restricted Stock Unitsderivative | -5,237 | $0.00 | $0 | 10,474 | Dec 20, 2024 |
| Oct 11, 2024 | OPRX OptimizeRx Corp | MOption exercise Common Stock | +8,222 | $0.00 | $0 | 35,432 | Oct 15, 2024 |
| Oct 11, 2024 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -2,066 | $6.63 | $14k | 33,366 | Oct 15, 2024 |
| Oct 11, 2024 | OPRX OptimizeRx Corp | MOption exercise Restricted Stock Unitsderivative | -8,222 | $0.00 | $0 | 0 | Oct 15, 2024 |
Questions about Edward Stelmakh
Answered from the filings on this page, as of the latest one.
Is Edward Stelmakh buying or selling?
In the last 12 months Edward Stelmakh reported 0 open-market buys worth $0 and 1 open-market sell worth $19k on SEC Form 4; the latest was sold $19k of OPRX on Dec 19, 2025. Grants, option exercises and tax withholding are not counted.
How did Edward Stelmakh's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Edward Stelmakh has 0.
Where does Edward Stelmakh file Form 4?
Edward Stelmakh has filed Form 4 at OPRX (OptimizeRx Corp) as Chief Finance & Strat Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.